Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European prospective investigation into cancer-eurgast cohort

International Journal of Cancer

Volumn 134, Issue 1, 2014, Pages 92-101

  Companioni, Osmel ^a   Bonet, Catalina ^a   Muñoz, Xavier ^a   Weiderpass, Elisabete ^b,c,d,e   Panico, Salvatore ^f   Tumino, Rosario ^g   Palli, Domenico ^h   Agnoli, Claudia ⁱ   Vineis, Paolo ^j,k   Boutron Ruault, Marie Christine ^l,m,n   Racine, Antoine ^l,m,n   Clavel Chapelon, Françoise ^l,m,n   Travis, Ruth C ^o   Khaw, Kay Tee ^p   Riboli, Elio ^j   Murphy, Neil ^j   Vergnaud, Anne Claire ^j   Trichopoulou, Antonia ^q,r   Benetou, Vassiliki ^q   Trichopoulos, Dimitrios ^r,s,t   Lund, Eiliv ^b   Johansen, Dorthe ^u   Lindkvist, Björn ^v   Johansson, Mattias ^w,x   Sund, Malin ^x   Ardanaz, Eva ^y,z   Sánchez Cantalejo, Emilio ^y,aa   Huerta, Jose M ^ab   Dorronsoro, Miren ^y,ac   Ramón Quirós, José ^ad   Tjonneland, Anne ^ae   Maxild Mortensen, Lotte ^af   Overvad, Kim ^af   Chang Claude, Jenny ^ag   Rizzato, Cosmeri ^ag   Boeing, Heiner ^ah   De Mesquita, H Bas Bueno ^ai,aj   Siersema, Peter ^aj   Peeters, Petra H M ^aj   Numans, Mattijs E ^aj   Carneiro, Fatima ^ak   Licaj, Idlir ^w   Freisling, Heinz ^w   Sala, Núria ^a   González, Carlos A ^a   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Cancer Registry of Norway ^*  (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

^e FOLKHÄLSAN RESEARCH CENTER   (Finland)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g CIVILE M P AREZZO HOSPITAL   (Italy)

^h CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁱ NATIONAL CANCER INSTITUTE   (Italy)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k Human Genetics Foundation   (Italy)

^l CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^m UNIVERSITÉ PARIS SACLAY   (France)

ⁿ IGR   (France)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^r HELLENIC HEALTH FOUNDATION   (Greece)

^s HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^t BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^u LUND UNIVERSITY HOSPITAL   (Sweden)

^v UNIVERSITY OF GOTHENBURG   (Sweden)

^w INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^x UMEÅ UNIVERSITY   (Sweden)

^y CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^z INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^aa ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ab DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ac BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ad PUBLIC HEALTH DIRECTORATE   (Spain)

^ae AALBORG UNIVERSITY HOSPITAL   (Denmark)

^af AARHUS UNIVERSITY   (Denmark)

^ag GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ah GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^ai NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^aj UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ak UNIVERSITY OF PORTO   (Portugal)

more..

Author keywords

CD14; gastric cancer; genetic susceptibility; Helicobacter pylori; NOD2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD14 ANTIGEN; TOLL LIKE RECEPTOR 4;

ADULT; ALLELE; ANATOMICAL CONCEPTS; ARTICLE; CANCER RISK; CD14 GENE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HAPLOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NFKB1 GENE; NOD2 GENE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ADENOCARCINOMA; TLR4 GENE;

CD14; GASTRIC CANCER; GENETIC SUSCEPTIBILITY; HELICOBACTER PYLORI; NOD2;

ADENOCARCINOMA; ANTIGENS, CD14; CARDIA; COHORT STUDIES; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84886890710     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28357     Document Type: Article

References (47)

1. Ferlay, J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2008; 127: 2893-917.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori: views and expert opinion of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 1994. ISBN 92 382 1261 4. ISSN 0250-9555.
3. Smith G, Hold GL, Tahara E, et al. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12: 2979-90.
4. Kumar H, Kawai T, Akira S,. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30: 16-34.
5. Armant MA, Fenton MJ,. Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol 2002; 29:3:reviews3011.
6. Tahara T, Shibata T, Hirata I, et al. CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a Japanese population. Dig Dis Sci 2009; 54: 1508-12.
7. Zhao D, Sun T, Zhang X, et al. Role of CD14 promoter polymorphisms in Helicobacter pylori infection related gastric carcinoma. Clin Cancer Res 2007; 13: 2362-68.
8. Tahara T, Arisawa T, Shibata T, et al. Association of polymorphism of TLR4 and CD14 genes with gastroduodenal diseases in Japan. Inflammopharmacology 2007; 15: 124-28.
9. Hold GL, Rabkin CS, Gammon MD, et al. CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer 2009; 18: 117-19.
10. Hnatyszyn A, Szalata M, Stanczyk J, et al. Association of c.802CNT polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients. Exp Mol Pathol 2010; 88: 388-93.
11. Wex T, Ebert MP, Kropf S, et al. Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany. Anticancer Res 2008; 28: 757-62.
12. Angeletti S, Galluzzo S, Santini D, et al. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population. Hum Immunol 2009; 70: 729-32.
13. Yazdanyar S, Nordestgaard BG,. NOD2/CARD15 genotype and common gastrointestinal diseases in 43 600 individuals. J Intern Med 2010; 267: 228-36.
14. Hold GL, Rabkin CS, Chow WH, et al. Polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007; 132: 905-12.
15. de Oliveira JG, Silva AE,. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 2012; 18: 1235-42.
16. Santini D, Angeletti S, Ruzzo A, et al. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol 2008; 154: 360-64.
17. Trejo-de la OA, Torres J, Pérez-Rodríguez M, et al. TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. Clin Immunol 2008; 129: 333-40.
18. Hishida A, Matsuo K, Goto Y, et al. Toll-like receptor 4 + 3725 G/C polymorphism Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobacter 2009; 14: 47-53.
19. Lo SS, Chen JH, Wu CW, et al. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery 2009; 145: 280-85.
20. Riboli E,. Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol 1992; 3: 783-91.
21. Carneiro F, Moutinho C, Pera G, et al. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol 2007; 42: 618-27.
22. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9.
23. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-65.
24. Sala N, Muñoz X, Travier N, et al. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study. Int J Cancer 2012; 130: 2417-27.
25. Palli D, Masala G, Del Giudice G, et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007; 120: 859-67.
26. González CA, Megraud F, Buissonniere A, et al. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol 2012; 23: 1320-24.
27. So HC, Sham PC,. Multiple testing and power calculations in genetic association studies. Cold Spring Harb Protoc 2011; 2011:pdb.top95. doi: 10.1101/pdb.top95.
28. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-53.
29. González JR, Armengol L, Solé X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007; 23: 644-5.
30. McLaren W, Pritchard B, Rios D, et al. Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor. Bioinformatics 2010; 26: 2069-70.
31. Reumers J, Pritchard B, Rios D, et al. Joint annotation of coding and non-coding single nucleotide polymorphisms and mutations in the SNP effect and PupaSuite databases. Nucleic Acid Res 2008; 36: D825-9.
32. Wang P, Zhang L, Jiang JM, et al. Association of NOD1 and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population. World J Gastroenterol 2012; 18: 2112-20.
33. Rosenstiel P, Hellmig S, Hampe J, et al. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 2006; 8: 1188-98.
34. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
35. Baldini M, Lohman IC, Halonen M, et al. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20: 976-83.
36. Wu MS, Cheng TY, Shun CT, et al. Functional polymorphisms of CD14 and toll like receptor 4 in Taiwanese Chinese with Helicobacter pylori related gastric malignancies. Hepatogastroenterology 2006; 53: 807-10.
37. Karhukorpi J, Yan Y, Niemela S, et al. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol 2002; 128: 326-32.
38. Correa P,. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-60.
39. Cao LX, Le Bousse-Kerdiles MC, Clay D, et al. Implication of a new molecule IK in CD34 hematopoietic progenitor cell proliferation and differentiation. Blood 1997; 89: 3615-23.
40. Baba T, Hanagiri T, Takenoyama M, et al. Identification of a lung cancer antigen evading CTL attack due to loss of human leukocyte antigen (HLA) class I expression. Cancer Sci 2010; 101: 2115-20.
41. Yoshiyama H, Imai S, Shimizu N, et al. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 1997; 71: 5688-91.
42. Kurt-Jones EA, Popova L, Kwinn L, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1: 398-401.
43. Corvalan A, Koriyama C, Akiba S, et al. Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer 2001; 94: 527-30.
44. Lee JH, Kim SH, Han SH, et al. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol 2009; 24: 354-65.
45. Garza-Gonzalez G, Bosques-Padilla FJ, Mendoza-Ibarra SI, et al. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 2007; 7: 70.
46. Gwang Kim J, Sohn SK, Chae YS, et al. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in patients with gastric cancer. Jpn J Clin Oncol 2009; 39: 497-501.
47. Lu R, Gao X, Chen Y, et al. Association of an NFKB1 intron SNP (rs4648068) with gastric cancer patients in the Han Chinese population. BMC Gastroenterol 2012; 12: 87.